Simplifying thryoid cancer 131I maximum permissible activity estimation

K Nichols, G Tronco, MB Tomas, K Bhargava… - 2020 - Soc Nuclear Med
1317 Background: Prior to administering 131 I for the treatment of thyroid cancer, blood
samples are taken every day over several days following administration of small activities of …
Save Cite Related articles
[PDF] snmjournals.orgFree from Publisher

Alternative means of estimating 131I maximum permissible activity to treat thyroid cancer

KJ Nichols, W Robeson, M Yoshida-Hay… - Journal of Nuclear …, 2017 - Soc Nuclear Med
To protect bone marrow from overirradiation, the maximum permissible activity (MPA) of 131I
to treat thyroid cancer is that which limits the absorbed dose to blood (as a surrogate of …
Save Cite Cited by 2 Related articles All 5 versions
[PDF] snmjournals.orgFree from Publisher

Assessment of simplified blood dose protocols for the estimation of the maximum tolerable activity in thyroid cancer patients undergoing radioiodine therapy using …

W Jentzen, A Bockisch… - Journal of Nuclear …, 2015 - Soc Nuclear Med
In high-activity radioiodine therapies for differentiated thyroid cancer, blood dosimetry has
been developed to estimate the maximum tolerable activity (MTA) of 131I that can be safely …
Save Cite Cited by 33 Related articles All 6 versions

The utility of percent 48-hour whole body retention for modifying empiric amounts of I-131 for the treatment of thyroid carcinoma

D Van Nostrand, F Atkins, K Kulkarni, K Burman… - 2006 - Soc Nuclear Med
1284 Objectives: Although whole body dosimetry can be used to determine the maximum
tolerated activity (MTA) of I-131 to treat metastatic well-differentiated thyroid carcinoma …
Save Cite Cited by 1 Related articles

Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic …

M Ruhlmann, W Sonnenschein… - Nuclear medicine …, 2018 - journals.lww.com
Pretherapeutic 124I dosimetry reliably predicts intratherape... : Nuclear Medicine
Communications Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics …
Save Cite Cited by 9 Related articles All 5 versions
[PDF] snmjournals.orgFree from Publisher

Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I

JC Sisson, BL Shulkin, S Lawson - Journal of Nuclear Medicine, 2003 - Soc Nuclear Med
There is no consensus on the amount of 131I for treatment of patients with well-differentiated
thyroid carcinoma; usual amounts vary widely. Body retention of 131I has been shown to be …
Save Cite Cited by 74 Related articles All 11 versions
[PDF] thieme-connect.com

Radioactive body burden measurements in 131 iodine therapy for differentiated thyroid cancer: Effect of recombinant thyroid stimulating hormone in whole body 131 …

R Ravichandran, A Al Saadi… - World Journal of Nuclear …, 2014 - thieme-connect.com
Protocols in the management of differentiated thyroid cancer, recommend adequate thyroid
stimulating hormone (TSH) stimulation for radioactive 131 I administrations, both for imaging …
Save Cite Cited by 14 Related articles All 13 versions

Determination of effective half-life of 131I in patients with differentiated thyroid carcinoma: comparison of cystatin C and creatinine-based estimation of renal function

M Freesmeyer, F Gühne, C Kühnel, T Opfermann… - Endocrine, 2019 - Springer
Purpose Renal function and effective half-life (t 1/2, eff) of I-131 have not been fully
elucidated in patients undergoing radioiodine therapy (RAIT) for differentiated thyroid cancer …
Save Cite Cited by 3 Related articles All 4 versions

Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH …

F Atkins, D VanNostrand, S Moreau, K Burman… - 2007 - Soc Nuclear Med
1217 Objectives: Previously (JNuclMed 2006: 47: 324P), we reported a bi-exponential
function (BF) that could estimate the maximum tolerated activity (MTA) of 131-I for the …
Save Cite Cited by 2 Related articles All 2 versions

Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

M Abuqbeitah, M Demir, L Kabasakal… - Nuclear Medicine …, 2018 - journals.lww.com
Aim The development of reliable dosimetry models promotes the individualized therapy
concept toward more success and less complications. This paper evaluates the traditional …
Save Cite Cited by 9 Related articles All 5 versions